Human CellExp TNFRSF4/OX40 /CD134, human recombinant protein
TNFRSF4, OX40, CD134, OX40L receptor, ACT35, TXGP1L
|Calculated MW||This protein is fused with 6× his tag at the C-terminus, and has a calculated MW of 21 kDa. The predicted N-terminus is Leu 29. DTT-reduced Protein migrates as 35-48 kDa in SDS-PAGE due to glycosylation.|
|Other Names||TNFRSF4, OX40, CD134, OX40L receptor, ACT35, TXGP1L|
|Results||Measured by its binding ability in a functional ELISA. Immobilized rh TNFRSF4 / OX40 / CD134 at 2 µg/ml (100 µl/well) can bind human TNFSF4 Fc Chimera. The EC50 of human TNFSF4 Fc Chimera is 30 ng/mL.|
|Application Notes||Centrifuge the vial prior to opening. Reconstitute in sterile PBS, pH 7.4 to a concentration of 50 µg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 month. For extended storage, it is recommended to store at -20°C.|
|Storage||-20°C; Lyophilized from 0.22 µm filtered solution in PBS, pH 7.4. Normally Mannitol or Trehalose is added as protectants before lyophilization.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is also known as ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, CD antigen CD134, OX40. OX40 / TNFRSF4 contains four TNFR-Cys repeats. TNFRSF4 is receptor for TNFSF4 / OX40L / GP34 and can interacts with TRAF2, TRAF3 and TRAF5.
Latza U.,et al.Eur. J. Immunol. 24:677-683(1994).
Baum P.R.,et al.Circ. Shock 44:30-34(1994).
Pankow R.,et al.J. Immunol. 165:263-270(2000).
Gregory S.G.,et al.Nature 441:315-321(2006).
Arch R.H.,et al.Mol. Cell. Biol. 18:558-565(1998).
If you have any additional inquiries please email technical services at email@example.com.